Companies: 10,795·Total market cap: $144.5T
Genetic Technologies Limited

Genetic Technologies Limited

GNTLFOTCHealthcare● Active
$1.00
+$0.00(+0.00%)
Market Cap$1.3B
P/E Ratio
52W High$1
52W Low$1

Genetic Technologies Limited(GNTLF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GNTLF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-062023-062022-062021-062020-06
Revenue
Revenue$9.67M$10.35M$9.22M$1.33M$0.84M
Cost of Revenue$3.76M$4.34M$0.32M$0.36M$0.10M
Gross Profit$3.90M$6.01M$6.47M($0.24M)$0.74M
Gross Margin %(computed)40.37%58.10%70.23%-18.02%87.89%
Operating Expenses
R&D Expenses$0.75M$1.28M$0.71M$1.17M$0.87M
G&A Expenses$10.22M$9.01M$2.18M$4.16M$2.31M
Total Operating Expenses$12.45M$12.08M$11.02M$6.96M$6.98M
Operating Income($12.21M)($6.07M)($4.81M)($5.80M)($5.94M)
Operating Margin %(computed)-126.23%-58.62%-52.19%-434.49%-708.77%
Interest Income$0.12M$0.22M$0.04M$0.06M$0.02M
Interest Expense$0.05M$0.03M$0.02M$0.01M$0.01M
Income Before Tax($12.02M)($11.91M)($7.16M)($7.08M)($6.29M)
Income Tax Expense$0.00M($0.16M)($0.03M)$0.00M($0.75M)
Net Income($12.02M)($11.75M)($7.13M)($7.08M)($6.29M)
Net Margin %(computed)-124.24%-113.56%-77.36%-530.26%-751.29%
Per Share & EBITDA
EPS (Basic)$-0.09$-0.12$-0.08$-0.08$-0.15
Wtd Avg Shares138.37M101.38M92.20M85.44M41.55M
EBITDA($11.43M)($11.20M)($7.20M)($7.16M)($5.87M)
EBITDA Margin %(computed)-118.17%-108.26%-78.11%-536.12%-700.99%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · AUD · M

深入了解Genetic Technologies Limited

关于Genetic Technologies Limited(GNTLF)损益表

Genetic Technologies Limited(GNTLF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,GNTLF实现营收$0.01B,毛利润$0.00B(毛利率40.37%),净利润($0.01B)(净利率-124.24%)。

常见问题

GNTLF · 4 问

Genetic Technologies Limited(GNTLF)2024财年营收为$0.01B,同比down6.5%。

GNTLF revenueGNTLF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09